Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants
Chunyan Yi, Xiaoyu Sun, Yixiao Lin, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
Masaud Shah, Hyun Goo Woo
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 216
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants
Daniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 19
Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein
Zhuocheng Yao, Lin Zhang, Yuange Duan, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106121-106121
Open Access | Times Cited: 14
Emerging SARS-CoV-2 variants: Why, how, and what's next?
Yu Chen, Qianyun Liu, Li Zhou, et al.
Cell Insight (2022) Vol. 1, Iss. 3, pp. 100029-100029
Open Access | Times Cited: 47
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment
Daniele Focosi, Scott A. McConnell, David J. Sullivan, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 100991-100991
Open Access | Times Cited: 32
SARS-CoV-2 spike protein in infectivity
Alaa Muayad Altaie, Rania Hamdy, Mohamed I. Husseiny, et al.
Elsevier eBooks (2025), pp. 21-56
Closed Access
Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patient
Hanno Schmidt, Luca Aroha Schick, Jürgen Podlech, et al.
npj Genomic Medicine (2025) Vol. 10, Iss. 1
Open Access
Molecular mechanistic exploration of conformational shifts induced by class IV anti-RBD antibody IY2A
Enhao Zhang, Song Luo, Xiaole Xu, et al.
International Journal of Biological Macromolecules (2025), pp. 141417-141417
Closed Access
E484K and N501Y SARS-CoV 2 spike mutants Increase ACE2 recognition but reduce affinity for neutralizing antibody
Sandipan Chakraborty
International Immunopharmacology (2021) Vol. 102, pp. 108424-108424
Open Access | Times Cited: 39
SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity
Sabari Nath Neerukonda, Russell Vassell, Sabrina Lusvarghi, et al.
Viruses (2021) Vol. 13, Iss. 12, pp. 2485-2485
Open Access | Times Cited: 32
Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness via HSPGs: A review and mechanistic hypothesis
Zhongyun Zhang, Juan Zhang, Jiqiu Wang
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 26
Emergence of Delta and Omicron variants carrying resistance-associated mutations in immunocompromised patients undergoing sotrovimab treatment with long-term viral excretion
Cristina Andrés, Alejandra González-Sánchez, Moraima Jiménez, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 2, pp. 240-246
Open Access | Times Cited: 25
Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2
Peng Yu, Jingping Ran, Ruiqi Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies
Masaud Shah, Hyun Goo Woo
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 30
The mechanisms of immune response and evasion by the main SARS-CoV-2 variants
Qiuli Chen, Jiawei Zhang, Peter Wang, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105044-105044
Open Access | Times Cited: 21
Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab
Clara Luzia Magnus, Andreas Hiergeist, Philipp Schuster, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
Yingqi Jin, C. Hou, Yonghao Li, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 16
The Impact of Mutation Sets in Receptor-Binding Domain of SARS-CoV-2 Variants on Stability of the RBD–ACE2 Complex
Mykyta Peka, Viktor Balatsky
Future Virology (2023) Vol. 18, Iss. 4, pp. 225-242
Open Access | Times Cited: 9
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy
Carmela De Marco, Claudia Veneziano, Alice Massacci, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 14
Modulated Cell Internalization Behavior of Icosahedral DNA Framework with Programmable Surface Modification
Kui Huang, Qiulan Yang, Min Bao, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 31, pp. 21442-21452
Closed Access | Times Cited: 2
Identification of antibody-resistant SARS-CoV-2 mutants via N4-Hydroxycytidine mutagenesis
Priya Kumar, Xiaoxiao Zhang, Rahul Shaha, et al.
Antiviral Research (2024) Vol. 231, pp. 106006-106006
Open Access | Times Cited: 2
Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization
Huimin Guo, Qing Fan, Shuo Song, et al.
Journal of Clinical Virology (2022) Vol. 150-151, pp. 105162-105162
Open Access | Times Cited: 12
Predicting the immune escape of SARS-CoV-2 neutralizing antibodies upon mutation
Divya Sharma, Puneet Rawat, Victor Greiff, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166959-166959
Open Access | Times Cited: 7
Jigsaw puzzle of SARS-CoV-2 RBD evolution and immune escape
Chunyan Yi, Xiaoyu Sun, Zhiyang Ling, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 7, pp. 848-851
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top